| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2926527
[patent_doc_number] => 05187098
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-02-16
[patent_title] => 'DNA encoding hybrid streptokinases with plasminogen fibrin binding domains'
[patent_app_type] => 1
[patent_app_number] => 7/888420
[patent_app_country] => US
[patent_app_date] => 1992-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8400
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/187/05187098.pdf
[firstpage_image] =>[orig_patent_app_number] => 888420
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/888420 | DNA encoding hybrid streptokinases with plasminogen fibrin binding domains | May 21, 1992 | Issued |
| 07/890362 | BONE CALCIFICATION FACTOR | May 21, 1992 | Abandoned |
Array
(
[id] => 3019080
[patent_doc_number] => 05326695
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-07-05
[patent_title] => 'Platelet derived growth factor agonists'
[patent_app_type] => 1
[patent_app_number] => 7/883949
[patent_app_country] => US
[patent_app_date] => 1992-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 22
[patent_no_of_words] => 9006
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/326/05326695.pdf
[firstpage_image] =>[orig_patent_app_number] => 883949
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/883949 | Platelet derived growth factor agonists | May 14, 1992 | Issued |
| 07/865411 | PHARMACEUTICAL COMPOSITIONS OF LIPOPHYLIC PROTEINS AND FORMULATION PROCESSES THEREFOR | May 6, 1992 | Abandoned |
| 07/876791 | BIOSYNTHETIC PROCESS FOR THE PREPARATION OF CHEMICAL COMPOUNDS | Apr 29, 1992 | Abandoned |
Array
(
[id] => 3101148
[patent_doc_number] => 05314994
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-24
[patent_title] => 'Inhibitor of tissue-type and urokinase-type plasminogen activators'
[patent_app_type] => 1
[patent_app_number] => 7/877271
[patent_app_country] => US
[patent_app_date] => 1992-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 24
[patent_no_of_words] => 25121
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/314/05314994.pdf
[firstpage_image] =>[orig_patent_app_number] => 877271
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/877271 | Inhibitor of tissue-type and urokinase-type plasminogen activators | Apr 28, 1992 | Issued |
Array
(
[id] => 3106482
[patent_doc_number] => 05407819
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-04-18
[patent_title] => 'Human plasminogen activator variants having amino acids 37-42 substituted and a method for their manufacture'
[patent_app_type] => 1
[patent_app_number] => 7/869380
[patent_app_country] => US
[patent_app_date] => 1992-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 12153
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/407/05407819.pdf
[firstpage_image] =>[orig_patent_app_number] => 869380
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/869380 | Human plasminogen activator variants having amino acids 37-42 substituted and a method for their manufacture | Apr 15, 1992 | Issued |
| 07/834534 | GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR AND DERIVATIVES THEREOF | Apr 9, 1992 | Abandoned |
| 07/864692 | RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHOD OF USE | Apr 6, 1992 | Abandoned |
| 07/863549 | DERIVATIVES OF HUMAN/BOVING BASIC FIBROBLAST GROWTH FACTOR | Apr 5, 1992 | Abandoned |
| 07/863540 | NOVEL FIBRINOLYTIC ENZYMES | Apr 5, 1992 | Abandoned |
| 07/861233 | METHODS AND COMPOSITIONS FOR GENE THERAPY, TUMOR THERAPY, VIRAL INFECTION THERAPY AND PREVENTION OF PROGRAMMED CELL DEATH (APOPTOSIS) | Mar 30, 1992 | Abandoned |
Array
(
[id] => 3455622
[patent_doc_number] => 05401643
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-03-28
[patent_title] => 'Method of preparing an active human neutrophil chemotactic factor polypeptide'
[patent_app_type] => 1
[patent_app_number] => 7/855471
[patent_app_country] => US
[patent_app_date] => 1992-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 3919
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/401/05401643.pdf
[firstpage_image] =>[orig_patent_app_number] => 855471
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/855471 | Method of preparing an active human neutrophil chemotactic factor polypeptide | Mar 22, 1992 | Issued |
| 07/855415 | ANTLER-DERIVED BONE GROWTH FACTORS | Mar 17, 1992 | Abandoned |
Array
(
[id] => 3055057
[patent_doc_number] => 05356875
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-10-18
[patent_title] => 'Anti-thrombin polypeptides and pharmaceutical compositions thereof'
[patent_app_type] => 1
[patent_app_number] => 7/842089
[patent_app_country] => US
[patent_app_date] => 1992-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 12506
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/356/05356875.pdf
[firstpage_image] =>[orig_patent_app_number] => 842089
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/842089 | Anti-thrombin polypeptides and pharmaceutical compositions thereof | Feb 25, 1992 | Issued |
Array
(
[id] => 3097657
[patent_doc_number] => 05314813
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-24
[patent_title] => 'Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines'
[patent_app_type] => 1
[patent_app_number] => 7/841662
[patent_app_country] => US
[patent_app_date] => 1992-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 24
[patent_no_of_words] => 38941
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/314/05314813.pdf
[firstpage_image] =>[orig_patent_app_number] => 841662
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/841662 | Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines | Feb 18, 1992 | Issued |
Array
(
[id] => 2947761
[patent_doc_number] => 05262308
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-11-16
[patent_title] => 'Cell lines which constitutively express IGF-1 and IGF-1 R'
[patent_app_type] => 1
[patent_app_number] => 7/827690
[patent_app_country] => US
[patent_app_date] => 1992-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5836
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/262/05262308.pdf
[firstpage_image] =>[orig_patent_app_number] => 827690
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/827690 | Cell lines which constitutively express IGF-1 and IGF-1 R | Jan 27, 1992 | Issued |
Array
(
[id] => 2889660
[patent_doc_number] => 05270198
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-12-14
[patent_title] => 'DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells'
[patent_app_type] => 1
[patent_app_number] => 7/824740
[patent_app_country] => US
[patent_app_date] => 1992-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 18531
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/270/05270198.pdf
[firstpage_image] =>[orig_patent_app_number] => 824740
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/824740 | DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells | Jan 20, 1992 | Issued |
Array
(
[id] => 3070698
[patent_doc_number] => 05360735
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-11-01
[patent_title] => 'DNA encoding a human 5-HT.sub.1F receptor, vectors, and host cells'
[patent_app_type] => 1
[patent_app_number] => 7/817920
[patent_app_country] => US
[patent_app_date] => 1992-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16464
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/360/05360735.pdf
[firstpage_image] =>[orig_patent_app_number] => 817920
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/817920 | DNA encoding a human 5-HT.sub.1F receptor, vectors, and host cells | Jan 7, 1992 | Issued |
| 07/810561 | NOVEL POLYPEPTIDE COMPONDS | Dec 19, 1991 | Abandoned |
